To continue reading this content, please enable JavaScript in your browser settings and refresh this page. <a href="http://www.bizjournals.com/profiles/company/us/wa ...
Seattle Genetics reported earnings on Tuesday. Despite the solid growth in sales, shares opened down today, possibly due to conservative guidance for the year ahead. Adcetris sales in the U.S. and ...
Shares of Seattle Genetics <a href="http://www.google.com/finance?hl=en&client=firefox-a&hs=IEB&rls=org.mozilla:en-US:official&q=sgen&um=1&ie ...
The FINANCIAL — Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited on October 28 announced that the companies have achieved completion of target patient enrollment in the phase 3 ECHELON ...
Seattle Genetics releases earnings on Thursday after the bell. Here are three things you should pay attention to as the company reports its first-quarter earnings. Beat and raise?As part of its fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results